Article
Depot-Specific Cardiorenal Adipose Remodeling with SGLT2i in Chronic Kidney Disease
2026-05-05
Abstract excerpt
<h4>Background: </h4> and hypothesis. Sodium–glucose cotransporter 2 inhibitors (SGLT2i) provide consistent cardiorenal benefits; however, tissue-level mechanisms remain insufficiently characterized. We investigated whether SGLT2i were associated with longitudinal remodeling of organ-specific adipose depots in patients with chronic kidney disease (CKD). Methods. In this observational study cohort (ADIPO-CKD; NCT07...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2abfeb8b-004a-52dd-a74d-c312a950b46c
- DOI
- 10.20944/preprints202605.0257.v1
